D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AKRO holding history
Akero Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −17,572−100.0% | Sold out | Holders |
| Q3 2025 | 17,572 | $834.3K | <0.1% | −36,294−67.4% | Reduced | Holders |
| Q2 2025 | 53,866 | $2.87M | <0.1% | +41,707+343.0% | Added | Holders |
| Q1 2025 | 12,159 | $492.2K | <0.1% | −23,650−66.0% | Reduced | Holders |
| Q4 2024 | 35,809 | $996.2K | <0.1% | −80,573−69.2% | Reduced | Holders |
| Q3 2024 | 116,382 | $3.34M | <0.1% | −199,335−63.1% | Reduced | Holders |
| Q2 2024 | 315,717 | $7.41M | <0.1% | −91,408−22.5% | Reduced | Holders |
| Q1 2024 | 407,125 | $10.3M | <0.1% | +196,165+93.0% | Added | Holders |
| Q4 2023 | 210,960 | $4.93M | <0.1% | +74,062+54.1% | Added | Holders |
| Q3 2023 | 136,898 | $6.92M | <0.1% | −274,221−66.7% | Reduced | Holders |
| Q2 2023 | 411,119 | $19.2M | <0.1% | +43,108+11.7% | Added | Holders |
| Q1 2023 | 368,011 | $14.1M | <0.1% | +74,167+25.2% | Added | Holders |
| Q4 2022 | 293,844 | $16.1M | <0.1% | +254,821+653.0% | Added | Holders |
| Q3 2022 | 39,023 | $1.33M | <0.1% | +28,353+265.7% | Added | Holders |
| Q2 2022 | 10,670 | $101.0K | <0.1% | +10,670 | New | Holders |